CRP and metabolic disease: Patients with ALS with comorbid metabolic disorders, neoplastic diseases, severe acute inflammation, or hematological abnormalities exhibit significantly reduced accuracy in laboratory markers (CRP, NLR, MLR, SII, and SIRI), and due to comorbidities, may face greater psychological stress, increasing their risk of depression.